Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by EMulate Therapeutics, Inc., a technology company based in Seattle, WA.
The ulRFE® technology, in which EMulate has invested approximately US$70 million to develop over the past 15 years, is backed by 32 patents that relate to Hapbee. Hapbee has exclusive global licenses for the non-medical use of ulRFE® technology.
You can learn more about therapeutic applications of ulRFE® technology at Scientific Platform.
CLICK VIDEO TO WATCH
